Permanently Discontinued

RAN-CLARITHROMYCIN

RANBAXY PHARMACEUTICALS CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is RAN-CLARITHROMYCIN discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that RAN-CLARITHROMYCIN 250MG has been permanently discontinued (last updated May 14, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is RAN-CLARITHROMYCIN not available?

The reason the manufacturer reported: Manufacturing issues.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength250MG

Last updated2020-05-14

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

RATIO-CLARITHROMYCIN

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

250MG · DIN 02247818

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

M-CLARITHROMYCIN

MANTRA PHARMA INC

250MG · DIN 02471388

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ CLARITHROMYCIN

SANDOZ CANADA INCORPORATED

250MG · DIN 02266539

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

PRO-CLARITHROMYCIN

PRO DOC LIMITEE

250MG · DIN 02324482

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

BIAXIN BID

BGP PHARMA ULC

500MG · DIN 02126710

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

BIAXIN

BGP PHARMA ULC

125MG · DIN 02146908

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02361426

Strength

250MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

CLARITHROMYCIN

See all CLARITHROMYCIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2020-05-14

Permanently Discontinued

Manufacturing issues

Other Products from RANBAXY PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

RAN-CITALO

40MG · DIN 02285630

RAN-CITALO

20MG · DIN 02285622

RAN-FENTANYL MATRIX PATCH

25MCG · DIN 02330113

RAN-FENTANYL MATRIX PATCH

75MCG · DIN 02330148

RAN-FENTANYL MATRIX PATCH

50MCG · DIN 02330121

RAN-FENTANYL MATRIX PATCH

100MCG · DIN 02330156